24 May 2013
Keywords: neurosearch, gets, 10m, gsk, uk, drug, major
Article | 04 April 2005
UK drug major GlaxoSmithKline will initiate Phase II clinical studies of Danish group NeuroSearch's NS2359 (GSK372475) to assess the agent's
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 April 2005
23 May 2013
© 2013 thepharmaletter.com